Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola) - PubMed (original) (raw)
Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola)
S P Fisher-Hoch et al. J Infect Dis. 1985 Nov.
Abstract
Eleven rhesus monkeys were monitored intensively during experimental infection with Ebola virus. Prominent neutrophilia with left shift and lymphopenia were the earliest abnormalities and were statistically significant by day 4 (P less than .02 and P less than .01, respectively). By day 4 falls in platelet counts were not statistically significant, whereas in vitro platelet aggregation was markedly depressed, progressing rapidly to complete failure by the time of maximum illness. Intraplatelet protein studies suggested this event was the result of in vivo activation and degranulation. Coagulation cascade defects were mainly in the intrinsic system and were surprisingly mild, with no evidence of selective consumption or production deficit of factor VII or VIII. When the possibility of indirectly mediated damage to endothelium possibly by a nonspecific immune response was examined, weight loss was less severe in drug-treated monkeys, and all had detectable plasma prostacyclin metabolites, but there was no improvement in survival.
Similar articles
- Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management.
Fisher-Hoch SP, Platt GS, Lloyd G, Simpson DI, Neild GH, Barrett AJ. Fisher-Hoch SP, et al. Lancet. 1983 Nov 5;2(8358):1055-8. doi: 10.1016/s0140-6736(83)91041-3. Lancet. 1983. PMID: 6138602 - Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever.
Fisher-Hoch SP, Mitchell SW, Sasso DR, Lange JV, Ramsey R, McCormick JB. Fisher-Hoch SP, et al. J Infect Dis. 1987 Mar;155(3):465-74. doi: 10.1093/infdis/155.3.465. J Infect Dis. 1987. PMID: 3543155 - [Experimental Ebola fever in Macaca mulatta].
P'iankov OV, Sergeev AN, P'iankova OG, Chepurnov AA. P'iankov OV, et al. Vopr Virusol. 1995 May-Jun;40(3):113-5. Vopr Virusol. 1995. PMID: 7676671 Russian. - Emerging roles of tissue factor in viral hemorrhagic fever.
Ruf W. Ruf W. Trends Immunol. 2004 Sep;25(9):461-4. doi: 10.1016/j.it.2004.07.002. Trends Immunol. 2004. PMID: 15324737 Review. - Clinical presentation and management of severe Ebola virus disease.
West TE, von Saint André-von Arnim A. West TE, et al. Ann Am Thorac Soc. 2014 Nov;11(9):1341-50. doi: 10.1513/AnnalsATS.201410-481PS. Ann Am Thorac Soc. 2014. PMID: 25369317 Review.
Cited by
- Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
Warfield KL, Olinger GG. Warfield KL, et al. J Biomed Biotechnol. 2011;2011:984241. doi: 10.1155/2011/984241. Epub 2011 Dec 28. J Biomed Biotechnol. 2011. PMID: 22253531 Free PMC article. Review. - Pathogenicity and virulence of Marburg virus.
Abir MH, Rahman T, Das A, Etu SN, Nafiz IH, Rakib A, Mitra S, Emran TB, Dhama K, Islam A, Siyadatpanah A, Mahmud S, Kim B, Hassan MM. Abir MH, et al. Virulence. 2022 Dec;13(1):609-633. doi: 10.1080/21505594.2022.2054760. Virulence. 2022. PMID: 35363588 Free PMC article. Review. - Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages.
Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. Feldmann H, et al. J Virol. 1996 Apr;70(4):2208-14. doi: 10.1128/JVI.70.4.2208-2214.1996. J Virol. 1996. PMID: 8642644 Free PMC article. - Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
Roe K, Gibot S, Verma S. Roe K, et al. Front Microbiol. 2014 Nov 26;5:627. doi: 10.3389/fmicb.2014.00627. eCollection 2014. Front Microbiol. 2014. PMID: 25505454 Free PMC article. Review. - Ebola haemorrhagic fever.
Feldmann H, Geisbert TW. Feldmann H, et al. Lancet. 2011 Mar 5;377(9768):849-62. doi: 10.1016/S0140-6736(10)60667-8. Lancet. 2011. PMID: 21084112 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical